Doctors in Perth are the first researchers to activate, enrol and deliver patient treatment in a multinational, multicentre Phase 3 nuclear medicine trial known as ProstACT GLOBAL, a study targeting advanced prostate cancer. …
Doctors in Australia lead Phase 3 theranostics study targeting advanced prostate cancer
November 6, 2024 Australian BiotechLatest Video
New Stories
-
AusBiotech and Life Sciences Western Australia sign first-ever MOU
November 7, 2024 - - Australian Biotech -
The solution simply gives some certainty to submissions that had none
November 7, 2024 - - Latest News -
Rare Cancers Australia set to launch the 2025 Kosi Challenge
November 7, 2024 - - Latest News -
'The fight is not over until this is all resolved, but seeing the system start to move is a great first step'
November 7, 2024 - - Latest News -
PBAC 'directed' to meet for another full meeting in May
November 6, 2024 - - Latest News -
Doctors in Australia lead Phase 3 theranostics study targeting advanced prostate cancer
November 6, 2024 - - Australian Biotech -
Scope of practice final report triggers debate over recommendations for reform
November 6, 2024 - - Latest News